1. Evolving trends in the management of pelvic inflammatory disease (PID) during SARS‐CoV‐2 pandemic: A multicenter retrospective cohort study.
- Author
-
Scutiero, G., Taliento, C., Vizzielli, G., Vitagliano, A., Soraci, G., Sabattini, A., Spelzini, F., Cappadona, R., Tormen, M., Arcieri, M., Ercoli, A., and Greco, P.
- Subjects
PELVIC inflammatory disease diagnosis ,STATISTICAL significance ,DISEASE management ,FISHER exact test ,TREATMENT effectiveness ,RETROSPECTIVE studies ,CHI-squared test ,MANN Whitney U Test ,DESCRIPTIVE statistics ,LONGITUDINAL method ,PELVIC inflammatory disease ,RESEARCH ,MEDICAL records ,ACQUISITION of data ,COMPARATIVE studies ,DATA analysis software ,COVID-19 pandemic - Abstract
Background and Aim: Pelvic inflammatory disease (PID) is usually managed by conservative treatment, but in selected cases, especially in the presence of a tubo‐ovarian abscess (TOA), surgical management is a recognized treatment option. We compared the trends in managing PID and short‐term outcomes before and during the SARS‐CoV‐2 pandemic. Methods: This is a retrospective study performed in three Italian gynecological centers. We included patients admitted to hospital with a diagnosis of PID. Demographic characteristics, management, time to diagnosis, and time to treatment were compared before versus during the SARS‐CoV‐2 pandemic. Results: One hundred nineteen PID patients were screened, eighty‐one before the SARS‐CoV‐2 pandemic, and thirty‐eight after the onset. At admission, leukocytosis (median 19.73 vs. 13.99 WBC/mm3, p‐value = 0.02) was significantly higher in patients who underwent surgery after the onset of the pandemic. TOA incidence was higher in patients who underwent surgery during the SARS‐CoV‐2 pandemic, but the difference did not reach statistically significance (p = 0.06). The proportion of patients treated with surgery dropped to 26.3% after the onset from 46% of patients before the onset of pandemic (p = 0.03). Furthermore, a higher percentage of emergency surgical procedures on day 0 of hospital admission were performed after the onset of the pandemic (50% vs. 13.1%, p = 0.01). Conclusions: In this retrospective cohort study, we found that the SARS‐CoV‐2 pandemic influenced the clinical presentation and management of PID in favor of conservative treatment. Patients who underwent surgery during the SARS‐CoV‐2 pandemic had higher inflammatory markers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF